Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Exagen Inc. - Common Stock
(NQ:
XGN
)
8.375
+0.035 (+0.42%)
Delayed Quote
Updated: 10:43 AM EST, Nov 4, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Exagen Inc. - Common Stock
< Previous
1
2
3
Next >
Exagen Inc. to Participate in Upcoming Investor Conferences
October 29, 2026
From
Exagen Inc.
Via
GlobeNewswire
Exagen to Announce Third Quarter Financial Results on November 10, 2026
October 27, 2026
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. Reports Second Quarter 2026 Financial Results
August 04, 2026
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. to Participate in Upcoming Investor Conference
July 28, 2026
From
Exagen Inc.
Via
GlobeNewswire
Exagen to Announce Second Quarter Financial Results on August 4, 2026
July 21, 2026
From
Exagen Inc.
Via
GlobeNewswire
Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE Lupus
June 01, 2026
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. Reports First Quarter 2026 Results
May 11, 2026
Delivers record total revenue and AVISE(R) CTD average selling price
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. to Announce First Quarter Financial Results on May 11, 2026
April 27, 2026
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2025 Results
March 10, 2026
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. to Participate in Upcoming Investor Conferences
March 03, 2026
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026
February 24, 2026
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. Announces Select Preliminary 2025 Financial Results
January 11, 2026
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. to Participate in Fourth Quarter Investor Conferences
November 11, 2025
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. Reports Strong Q3 2025 Results
November 04, 2025
From
Exagen Inc.
Via
GlobeNewswire
Exagen Announces Acceptance of Six Abstracts at 2025 American College of Rheumatology Convergence
October 23, 2025
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. to Announce Third Quarter 2025 Financial Results on November 4, 2025
October 21, 2025
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. to Participate in Third Quarter Investor Conferences
August 06, 2025
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. Reports Strong Q2 2025 Results
July 29, 2025
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. Appoints Chas McKhann to Board of Directors
July 17, 2025
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. to Announce Second Quarter 2025 Financial Results on July 29, 2025
July 15, 2025
From
Exagen Inc.
Via
GlobeNewswire
Michael Mahler, PhD Joins Exagen as Chief Scientific Officer to Enhance Leadership in Autoimmune Diagnostics
June 23, 2025
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares
May 09, 2025
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. Prices Public Offering of Common Stock
May 08, 2025
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. Announces Proposed Public Offering of Common Stock
May 07, 2025
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. Reports Record Q1 2025 Revenue Driven by Growth in Average Selling Price and Testing Volume
May 05, 2025
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. Announces Senior Secured Credit Facility with Perceptive Advisors
April 28, 2025
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. to Announce First Quarter 2025 Financial Results on May 5, 2025
April 21, 2025
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2024 Results and Business Highlights
March 11, 2025
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. to Announce Fourth Quarter and Full-Year 2024 Financial Results on March 11, 2025
February 25, 2025
From
Exagen Inc.
Via
GlobeNewswire
Exagen Inc. to Participate in Upcoming Investor Conferences
February 04, 2025
From
Exagen Inc.
Via
GlobeNewswire
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
